A common diabetes drug may prevent leukemia, mouse study suggests (Metformin)

Metformin, a widely used diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk of the disease, a study in mice has suggested. Acute myeloid leukemia (AML) is an aggressive form of blood cancer that is very difficult to treat. Thanks to recent advances, individuals at high risk of AML can be identified years in advance using blood tests and blood DNA analysis, but there's no suitable treatment that can prevent them from developing the disease. In this study, Professor George Vassiliou investigated how to prevent abnormal blood stem cells with genetic changes from progressing...